News for Control Bionics Limited (CBL.AX)

Australian medical device company Control Bionics (ASX: CBL) is expecting US revenue for the first six months of the 2025 financial year to increase by

Control Bionics (ASX: CBL) has expanded into the US sports performance and Japanese neurological rehabilitation markets with the first commercial

Australia’s second largest bank Westpac (ASX:WBC) has been down around 1.3% after appointing Anthony Miller as its new CEO.

An agreement between Control Bionics Ltd and Smart Box Ltd will see the latter become exclusive distributor of the NeuroNode wireless device.

Control Bionics (ASX: CBL) has announced that the US Centers for Medicare & Medicaid Services (CMS) have approved a new healthcare common procedure

An autonomous wheelchair module developed by Control Bionics (ASX: CBL) will be launched on the local market after being listed on the Australian register

Control Bionics enables disabled people to use their own ‘brain- to-muscle’ electrical signals to control communication and movement.

Control Bionics launched the world's first autonomous driving wheelchair, DROVE at Deakin University’s new Digital Health Lab.

The ASX 200 gained 0.57% today and the ASX XEC was down 0.08%, with 8 out of 11 sectors higher, led by Materials which rallied by 1.02%.

Closing Bell: Sapped of energy, small cap index ends head-banging June almost 20pc out of tune

Aussie small caps have copped a commodities shellacking as materials, metals and energy stocks bear the brunt of the economic angst